淘汰GBP5通过调节NF-κB/STAT3通路来缓解牛皮引起的损伤
Fang Ren1, Jin Li1, Xingyan Ni1
1Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Allergologia et immunopathologia
|November 8, 2024
概括
抑制瓜尼酸结合蛋白5 (GBP5) 可以减轻牛皮的损伤. 这项研究发现牛皮的高GBP5表达,并显示其抑制通过NF-κB/STAT3通路减少炎症和损伤.
科学领域:
- 皮肤病学 皮肤病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 牛皮会导致严重的功能障碍,影响患者的福祉.
- 关酸结合蛋白5 (GBP5) 涉及炎症,但其在牛皮相关脏问题中的作用尚不清楚.
研究的目的:
- 确定英5英作为牛皮引起的功能障碍的新治疗标.
- 阐明英5通过哪些机制影响牛皮的损伤.
主要方法:
- 在牛皮的皮肤中使用免疫斑块和qPCR分析了GBP5表达.
- 在体外模型中使用TNF-α来模拟牛皮,评估细胞活力和炎症.
- 在体内模型 (IMQ刺激的小鼠) 评估了牛皮症状和损伤.
- 机理学研究使用免疫阻塞来确认途径的参与.
主要成果:
- 在牛皮的皮肤组织中,GBP5显著上调.
- GBP5抑制降低了TNF-α诱导的角质细胞生长和炎症.
- 敲击5英改善了小鼠的牛皮症状,减少了小鼠的损伤.
- 5英的耗尽抑制了NF-κB/STAT3信号通路.
结论:
- 抑制GBP5提供了一种潜在的治疗策略,以减轻与牛皮相关的损伤.
- GBP5抑制的保护作用是通过抑制NF-κB/STAT3轴的介导.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142


